TABLE 3.
Odds ratio that a subject experienced a clinical adverse event of moderate or severe intensity by specific regimens
| IDV-RTV doses | Odds ratio (OR) | 95% CI | P |
|---|---|---|---|
| 400-400 over 800-100 | |||
| All participants enrolled | 7.50 | 1.36, 41.31 | 0.021 |
| All participants completing studya | 6.0 | 0.83, 43.17 | 0.075 |
| 400-400 over 800-200 | |||
| All participants enrolled | 1.13 | 0.20, 6.26 | 0.893 |
| All participants completing studya | 1.50 | 0.22, 10.31 | 0.680 |
| 400-400 over 800-400 | |||
| All participants enrolled | 0.68 | 0.11, 3.99 | 0.665 |
| All participants completing studya | 0.75 | 0.11, 5.15 | 0.770 |
a
Excluding participants who discontinued the study prematurely.